Assessment of performance of routine clinical biochemistry tests based on total allowable error criteria
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2023
Project Lead
Ms. Zeenath Latheef
Authors
Ms. Zeenath Latheef, Dr Jyothi D N
Project Status
completed
Project Type
Student Project